Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9750822 | LUPIN | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
US7635773 | LUPIN | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
US8410077 | LUPIN | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
US9200088 | LUPIN | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
US9493582 | LUPIN | Alkylated cyclodextrin compositions and processes for preparing and using the same |
Feb, 2033
(8 years from now) |
Market Authorisation Date: 05 November, 2020
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS